Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001725663-25-000004

Chief Financial Officer sold 8,910 shares at $9.98 ($88,932)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

WENTWORTH KORY JAMES · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-11-21 Sale : show line 1 in the form 10b5-1 −8,910 $9.98 $88,932 110,026 D
Open-market sales · 8,910 sh · avg $9.98 · $88,932
Loading xslF345X05/wk-form4_1764019838.xml…